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Abstract: Subclinical lung function alterations can sometimes be discovered in asthmatic patients under clinical control. 
This study aimed to identify the burden of asthmatic children with subclinical airways abnormalities who may benefit 
from an adjustment in asthma therapy. 134 6-to-17-year-old asthmatic children were enrolled. Of them, 98 presented ap-
parently under clinical control disease and all performed spirometry before and after bronchodilation: 17 (17.3%) had a 
positive bronchodilation test, in addition to significantly lower lung function indexes as compared to those with under-
control asthma who had a negative bronchodilation test. These patients were randomized and re-evaluated: patients (n=8) 
receiving an adjustment in their therapy showed an improvement in lung function tests and quality of life indexes as com-
pared to 7 without therapy adjustment. In conclusion, a substantial number of apparently-under-control asthmatic children 
show airways alterations that can be improved by adjusting their therapy, which also seems to enhance their quality of 
life. 
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INTRODUCTION 
  Asthma is the most frequent chronic disease in childhood 
and its prevalence is increasing [1,2], but only a part of the 
patients reach the goals of control set out by the Global Ini-
tiative for Asthma (GINA) [3,4]. Adequate therapy may limit 
bronchial inflammation, thus improving the health status of 
the asthmatic child and preventing the disease severity from 
worsening [3]. The more severe asthma is in childhood, the 
more likely it is that the disease will persist in adulthood [5]. 
The main goal to be achieved in the management of the 
asthmatic child is to obtain a control both of the symptoms 
and of subtle airways alterations that can only be revealed by 
laboratory exams. 
  Lung function testing and the measurement of bronchodi-
lation responsiveness are recommended for the diagnosis of 
asthma and for its monitoring over time [3]. The post-
bronchodilation forced expiratory volume at the first second 
(FEV1) measures the best lung function that can be achieved 
by bronchodilator therapy on the day of the visit [6]; a 
suboptimal post-bronchodilation FEV1 indicates bronchial 
obstruction. 
  Several studies confirm that lung function can be altered 
even in patients whose disease is judged to be under control 
according to their symptoms referral and the use of reliever 
medications [4,7,9]. Collecting symptoms from the children 
or their parents can though be troublesome. A non-
recognition of the symptoms can lead to an underestimation 
of the severity of asthma, consequently to inappropriate 
treatment, and eventually to a worsening of the disease se-
verity. 
  It seems that taking into account only the symptoms as 
referred by the children or their parents in order to judge 
asthma control is insufficient [7-9]. The present study aimed  
 
 
*Address correspondence to this author at the Department of Paediatrics, S. 
Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; E-mail: 
giampaolo.ricci@unibo.it 
to demonstrate the usefulness of performing spirometry and 
the bronchodilation test in asthmatic children during routine 
clinical visits in order to monitor their actual asthma control 
and severity. 
MATERIALS AND METHODOLOGY 
Patients 
  134 children (98 males) aged 6 to 17, who had been con-
secutively referred to the Allergology. Outpatient section of 
our clinic between November 2005 and October 2006, were 
included, all having a diagnosis of allergic asthma which had 
been established previously. 
  All the patients underwent a clinical examination to as-
sess their asthma severity according to the GINA guidelines 
[3], and the status of asthma control on the basis of the pa-
rameters suggested by the Joint Task Force on Practice Pa-
rameters for Allergy and Immunology [10]. A child was con-
sidered to be clinically under control if, in the previous two 
weeks, there had been: 1) asthma symptoms twice a week or 
less; 2) rescue bronchodilator use twice a week or less; 3) no 
nighttime or early morning awakening; 4) no limitations on 
exercise, work, school; 5) well-controlled asthma by patient 
and physician assessment; 6) normal or personal best FEV1; 
7) absence of bronchospasm at auscultation. Therapy prior to 
the visit was recorded. 
Lung Function Testing 
  All the patients performed a spirometry by means of a 
Multispiro SA/100 spirometer (Medical Equipment Designs, 
Laguna Hills, CA, USA). The best of a minimum of three 
recordings was chosen and a bronchodilation test was done 
by the administration of 200 mcg of dry salbutamol powder 
and repetition of the spirometry 15 minutes later. Spiromet-
ric indices were expressed as percentage of the predicted 
values (Polgar revisited) [11]. The result of the bronchodila-
tion test was evaluated by examining the variation in FEV1 
before and after bronchodilation expressed as a percentage 
change relative to the baseline values (deltaFEV1): the test 
was considered positive when deltaFEV1 was 12% [7,12, 2    The Open Respiratory Medicine Journal, 2008, Volume 2  Ricci et al. 
13]. We chose the value of deltaFEV1 12% instead of 15% 
to increase the sensibility of the test. 
Skin Prick Tests (SPT) 
  A Skin Prick Test was performed to establish possible 
sensitization to the main seasonal (grass pollens, Parietaria 
judaica) and perennial (Dermatophagoides farinae,  Der-
matophagoides pteronyssinus, Alternaria alternatae, cat and 
dog dander) allergens involved in allergic asthma (Lofarma, 
Milan, Italy). 
Health-Related Quality of Life (HRQL) 
  Patients’ HRQL was measured by administering the Pe-
diatric Asthma Quality of Life Questionnaire (PAQLQ) [14]. 
Statistical Analysis 
  Data were examined by means of SPSS 13.0 for Win-
dows (SPSS/PC; SPSS Inc., Chicago, IL, USA). Student’s t-
test and linear regression were used. Results were considered 
significant for a p value 0.05. 
Ethical Consideration 
  This research was conducted in accordance with the prin-
ciples of the Declaration of Helsinki. Written informed con-
sent was obtained from parents before the children were in-
cluded in the study. 
RESULTS 
  According to our parameters, the asthma was under con-
trol in 98 children (73.1%), but not in the remaining 36 
(26.9%). Of the 98 children with controlled disease, 17 
(17.3%) had a positive bronchodilation test, meaning a del-
taFEV1 12%. This allowed us to divide our population into 
three different groups, one including patients with their 
asthma under control and with a negative bronchodilation 
test, the second consisting of children with controlled asthma 
but a positive bronchodilation test and the third including 
patients with uncontrolled asthma. Table 1 describes the 
main clinical and functional characteristics of our popula-
tion. Table 2 shows the results of spirometry, bronchodila-
tion test, Skin Prick Test and PAQLQ scores. 
  Firstly, differences in spirometric data between different 
groups in our population were examined. Results of t-test 
showed that FEV1 and the ratio between FEV1 and the forced 
vital capacity (FVC) differed significantly (p0.001 and 
p0.005 respectively) between patients with apparently under 
control asthma (with a positive or negative response to the 
bronchodilation test) and patients with not-controlled asthma. 
 Moreover,  FEV1 and FEV1/FVC differed significantly 
(p0.05 and p0.01 respectively) between patients with 
asthma under control and a positive or negative response to 
the bronchodilation test. No significant differences were 
found in FVC between these groups. FEV1 and FEV1/FVC 
were not significantly different (p=0.180 and p=0.785 re-
spectively) between patients with asthma under control but a 
positive bronchodilation test and patients with uncontrolled 
asthma. 
  Analysis of the differences in HRQL between groups 
showed that PAQLQ scores were similar in all children with 
asthma under control independently of bronchodilation test 
results, but a statistically significant difference was found 
between the scores of children with controlled asthma and a 
positive bronchodilation test, and children with uncontrolled 
disease (p0.01). 
Table 1.  Main Clinical and Spirometric Characteristics of 134 Children (Mean Age 10.95; 98 Males and 36 Females) Enrolled in 
the Study 
 
Under Control (n=98) 
  Negative Bronchodilation 
Test (n=81) 
Positive Bronchodilation 
Test (n=17) 
Not Under  
Control (n=36) 
All Patients  
n=134 
34 (42%)  7 (41 %) 
Intermittent 
41 (42%) 
7 (19%)  48 (36%) 
40 (50%)  7 (40%) 
Mild persistent 
47 (48%) 
19 (53%)  66 (49%) 
7 (9%)  3 (18%) 
Moderate persistent 
10 (10%) 
7 (19%)  17 (13%) 
0 0 
Asthma severity 
Severe persistent 
0 
3 (8%)  3 (2%) 
50 (51%)  8 (47%) 
ICS
* 
42 (52%) 
17 (47%)  67 (50%) 
11 (11%)  2 (12%) 
ICS
* + LABA
† 
9 (11%) 
6 (17%)  17 (13%) 
37 (38%)  7 (41%) 
Controller medications 
Only reliever medications 
30 (37%) 
13 (36%)  50 (37%) 
*ICS: inhaled corticosteroids; 
†LABA: long-acting 2agonists; bronchodilation test was considered to be positive when deltaFEV112%; deltaFEV1= (FEV1postBD-FEV1at baseline) 
/ FEV1 at baseline. Asthma Control in Children  The Open Respiratory Medicine Journal, 2008, Volume 2    3 
  Examination of the allergic condition in the population 
did not highlight differences between the three groups re-
garding positive Skin Prick Test to the main allergens in-
volved in allergic asthma (Table 3). 
Table  3.  Main Allergic Characteristics of 134 Children In-
cluded in Our Study 
 
  Grass  
Pollens 
House  
Dust Mites 
Cat  
Dander 
Under control, negative  
bronchodilation test  
(n=81) 
72 (88.9%)  36 (44.4%)  31 (38.3%) 
Under control, positive  
bronchodilation test  
(n=17) 
14 (82.4%)  5 (29.4%)  4 (23.5%) 
Not under control  
(n=36) 
32 (88.9%)  19 (52.8%)  15 (41.7%) 
No differences between the three groups are statistically significant. 
 
  Patients showing a discrepancy between the results of 
spirometry and asthma control were proposed to be re-
evaluated after a few months in order to reassess their 
asthma control and lung function. These patients were ran-
domized and divided in two groups: 8 children (first group) 
had an adjustment in their asthma therapy, consisting of the 
introduction of or increase in inhaled corticosteroids (ICS), 
which have been shown to provide an improvement in air-
way responsiveness and asthma control [15]. Remaining 9 
children (second group) had no adjustment in their therapy. 
Two children of the second group missed the visit. Table 4 
shows the spirometric values and PAQLQ scores in the two 
subgroups of patients at the first visit. No significant differ-
ences were found between the two groups. 
  Fifteen children were re-evaluated after 1 to 4 months, 8 
of whom had had their therapy adjusted and 7 had not. Con-
trol of spirometry showed that 7 (87.5%) of the 8 children 
with a change in their therapy had a negative response to the 
bronchodilation test and 1 (12.5%) had a positive response, 
whereas among the patients with no change in asthma ther-
apy 3 (42.9%) had a negative bronchodilation test, and the 
remaining 4 (57.1%) had an increase in FEV1 after salbuta-
mol 12% (Fig. 1). 
  The same group of patients completed the PAQLQ again 
at the second visit. Median values showed an improvement 
in HRQL in those children who had been treated with ICS 
(6.48 at the first time, 6.72 at the second), and a worsening in 
children whose therapy had not been modified (6.73 and 
6.39), but differences are not statistically significant. The 
examination of the subscales of the questionnaire indicates 
that 5 out of 8 children who had been treated with ICS had 
an improvement in the “activity limitations” domain, 
whereas only 2 out of 7 children who had not been treated 
with ICS showed this enhancement. 
DISCUSSION 
  The main goal in the management of the asthmatic child 
is to obtain control of the disease, but subclinical alterations 
Table 2.  Results of Spirometry, Bronchodilation Test, Skin Prick Test and PAQLQ Scores 
 
Under Control (n=98) 
  Negative Bronchodilation 
Test (n=81) 
Positive Bronchodilation 
Test (n=17) 
Not Under 
Control n=36 
All Patients 
n=134 
106.% ± 13.5%  110%±15% 
Mean FVC ± SD 
107%±14% 
99%±16 105%±15% 
99%± 12% § 92%±10%  § 
Mean FEV1 ± SD 
97%±18% $ 
85%±20 $  94%± 
15.5% 
94%±9.6% #  84%±11% # 
Mean FEV1/FVC ± SD 
92%±10.5% ¥ 
85.05%±13 ¥  90%± 12% 
0 17  (100%) 
Delta FEV1
*12% 
17 (17%) 
17 (47%)  34 (25%) 
85 (87%)  14 (82%) 
Grass pollens 
71 (88%) 
32 (89%)  117 (87%) 
41 (42%)  5 (29%) 
House dust mites 
36 (44%) 
19 (53%)  60 (45%) 
35 (36%)  4 (23.5%) 
SPT
† positive results 
Cat dander 
31 (38%) 
15 (42%)  50 (37%) 
6.18±0.75 6.43±0.52 
Mean PAQLQ
‡ score ± SD 
6.23±0.72 
5.42 ±1.18  6.02±0.93 
Spirometric data are expressed as percentage of predicted. Statistics showed significant statistical differences in FEV1 and in FEV1/FVC between children with apparently under 
control asthma and with not-controlled asthma ($: p0.001 and ¥: p0.005 respectively) and between children with under control asthma and a negative or positive response to bron-
chodilation (§: p0.05 and #: p0.01 respectively).  
*deltaFEV1= (FEV1 post bronchodilation – FEV1 at baseline) / FEV1 at baseline; †SPT: Skin Prick Test; ‡PAQLQ: Pediatric Asthma Quality of Life Questionnaire. 4    The Open Respiratory Medicine Journal, 2008, Volume 2  Ricci et al. 
can be occasionally revealed in the lung function of asth-
matic patients under apparent clinical control. No specific 
guidelines could be found about the approach to this prob-
lem, even if several studies reported such discrepancies, and 
the fact that asthma control is poorly judged when symptoms 
alone are considered has already been stated [7,8,16-19]. 
  Korhonen  in 1999 evaluated the treatment policy for 
asthmatic children in the area of Kuopio, Finland [8]. PEF, 
spirometry and bronchodilation test results were collected 
from 195 school-aged patients. 11% of them had a positive 
the bronchodilation test as the only sign of bronchial ob-
struction, pointing to inadequate therapy. 
  Our study shows a prevalence of 17.3% of positive bron-
chodilation tests in a group of asthmatic children who were 
in a symptom-free period, indicating an occult bronchial 
obstruction. The lung function of these children was more 
similar to that of children with uncontrolled asthma than to 
the one of those with controlled asthma and a negative bron-
chodilation test. 
  The reasons why these children are asymptomatic despite 
having pulmonary function impairment can be multiple. First 
of all, an underlying, but still subclinical, pathological proc-
ess in the airways could be hypothesized, similarly to what 
happens in some patients with apparently outgrown disease 
Table 4.   Spirometric Values and PAQLQ Scores at the First Visit in the Two Subgroups of Patients with Positive Bronchodilation 
Test (n=17) who had an Adjustment in their Asthma Therapy (First Group; n= 8), Consisting of the Introduction of or 
Increase in Inhaled Corticosteroids (ICS), and who had No Adjustment in their Therapy (Second Group; n=9) 
 
  Patients with Adjustment  
in Therapy (n=8) 
Patients without Adjustment  
in Therapy (n=9) 
All Patients with Positive  
Bronchodilation Test (n=17) 
p Value 
Mean  
FVC ± SD 
107%± 
15% 
112%±14%  110% 
± 15% 
0.475 
Mean 
FEV1 ± SD 
91%± 
10% 
92%±10%  92% 
±10% 
0.840 
Mean FEV1/FVC 
± SD 
86%± 
12% 
82%±10%  84% 
±11% 
0.465 
Mean 
Delta FEV1
*± SD  
19%± 
6% 
16%±6%  17.5% 
±6% 
0.320 
Mean PAQLQ
‡  
score ± SD 
6.48±0.79 6.73±0.55  6.43 
±0.52 
0.456 
No differences between the two groups are statistically significant.  
* Delta FEV1 = (FEV1 post bronchodilation - FEV1 at vaseline) / FEV1 at baseline; ‡PAQLQ: Pediatric Asthma Quality of Life Questionnaire. 
 
Fig. (1). Variation in FEV1 before and after bronchodilation in 15 children who had previously shown a positive bronchodilation (BD) test. 
The BD test was considered to be positive when variation in FEV1 at baseline and after bronchodilation, expressed as a percentage of the 
baseline value, was 12%. Asthma Control in Children  The Open Respiratory Medicine Journal, 2008, Volume 2    5 
[20-22]. Secondly, patients with asthma frequently have poor 
recognition or perception of their symptoms [3,22,23]. Bou-
let  [22] in 1994 showed that the perception of symptoms 
associated with airways obstruction follows a normal uni-
modal distribution in the population with asthma; there are 
some “hypoperceivers” who can be asymptomatic or have 
minimal symptoms even with marked reductions in expira-
tory flows. A poor sensibility of airways obstruction has 
been demonstrated when convalescing from an acute asth-
matic attack, during regular follow-ups, during a stable state 
of asthma, and even during acute episodes [18,24-27]; some 
patients have difficulty in distinguishing asthmatic dyspnoea 
from exercise-induced physiological breathlessness [28]. 
Moreover, collecting the symptoms story from the parents 
can sometimes be misleading on the actual status because of 
the social and psychological impact of admitting having a 
child with asthma; collecting the symptoms report directly 
from the kids could be more accurate [29], even if children, 
and mainly adolescents [5], may deny symptoms. 
  We believe that patients with a positive response to the 
bronchodilation test even in the absence of symptoms should 
be regarded as undertreated. Our data on lung function after 
treatment (figure 1) show an improvement in most of the 
patients. On the contrary, 4 children out of 7, who were not 
treated after positive bronchodilation test, did not show an 
improvement in lung function at re-evaluation. The reason 
why more than 40% of children with unmodified therapy 
also showed an improvement in lung function can be im-
puted to the fact that a more stringent medical control often 
induces a patient’s better compliance to therapy and disease 
management. 
  The administration of the PAQLQ did not reveal any 
differences in HRQL between children with under-control 
asthma but a different response to bronchodilation. All of 
them, however, had a significantly better HRQL than chil-
dren with uncontrolled disease. Although HRQL evaluation 
does not help to identify patients in need of further therapy, 
it is interesting to note that controlled patients with a positive 
bronchodilation test have some characteristics (asthma con-
trol, HRQL) in common with those well controlled and not 
respondent to bronchodilation, while they are more similar to 
uncontrolled children for other features (lung function). 
  However, PAQLQ re-administration in the 15 children 
who repeated spirometry because of the discrepancy between 
clinical and functional data indicates an improvement in 
HRQL in those who underwent ICS therapy or had an aug-
mentation in the dosage. Their activity limitations seem to be 
the most concerned, because 5 children out of 8 improved in 
this domain of the questionnaire. 
  The first studies which identified such discrepancies be-
tween lung function and clinical control were conducted 20 
to 30 years ago. Even if since then new drugs have been de-
veloped, asthma has been widely studied and its diagnosis 
and treatment have generally improved, the point of asymp-
tomatic airways alterations is still up-to-date. Adequate 
treatment prevents pulmonary function from worsening: in 
persistent asthma, ICS suppress airway inflammation, reduce 
airway hyperresponsiveness, improve asthma control and 
prevent symptoms [3,15]. Persistent abnormal lung function 
in childhood, measured either at baseline or after bronchodi-
lation, is probably associated with more severe asthma and 
an unfavourable prognosis [5]. The limitation of our study is 
that it does not include Exhaled Nitric Oxide measurements, 
which could add further informations on the inflammatory 
status and, therefore, on asthma control [30]. This device is 
very useful in clinical practice, but, by now, it is not still 
available in all pneumologic and allergologic center. 
  Undertreated patients are exposed to a worse progression 
of asthma severity and the bronchodilation test, even in the 
absence of Nitric Oxide measurements, seems to identify 
those children who are in need of a reassessment of their 
therapy. Moreover, our results indicate that the pharmacol-
ogical treatment of an occult bronchial obstruction helps 
improving HRQL. 
CONCLUSION 
  In conclusion, we believe that it is advisable to perform 
spirometry in asthmatic children in order to provide adequate 
therapy for their actual lung condition, which can be re-
vealed by the bronchodilation test. Establishing asthma con-
trol solely on the basis of clinical parameters could be insuf-
ficient. In the absence of Nitric Oxide measurements, spi-
rometry is a simple examination which is normally perform-
able in every pneumologic or allergologic outpatient clinic 
and allows an evaluation of the bronchial obstruction status 
of the lung of the asthmatic school-aged child without any 
further, expensive investigation. 
ABBREVIATIONS 
BD test  =  Bronchodilation test 
FEV1  =  Forced expiratory volume at the first second 
FVC  =  Forced vital capacity 
HRQL  =  Health-related quality of life 
ICS =  Inhaled  corticosteroids 
LABA =  Long-acting  2agonists 
PAQLQ  =  Pediatric Asthma Quality of Life Questionnaire 
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